Head-to-head · Cost-Efficiency Index
FORM vs LumiMeds
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
FORM
Shoppers who want compounded GLP-1, a branded option, and adjacent longevity or hair-loss products in one place, and will confirm the branded drug's real cost before enrolling.
Visit FORMLumiMeds
Shoppers willing to prepay a longer term to chase the lowest advertised rate, and who value a named, board-certified medical director.
Visit LumiMedsThe verdict
FORM and LumiMeds tie on the Cost-Efficiency Index at 60/100, so neither wins outright on the numbers. For most shoppers we'd start with FORM (ranked #242, a hair above #243) — Shoppers who want compounded GLP-1, a branded option, and adjacent longevity or hair-loss products in one place, and will confirm the branded drug's real cost before enrolling. But LumiMeds is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs FORM.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | FORM | LumiMeds |
|---|---|---|
| Cost-Efficiency Index | 60/100 | 60/100 |
| Semaglutide / mo | $299/mo (compounded, no dose tiers shown) | $99/mo (starting dose, 12-month plan, compounded) |
| Tirzepatide / mo | Not disclosed | $183/mo (starting dose, prepay plan, compounded) |
| Semaglutide / yr (modeled) | $3,588 | $1,188 |
| Tirzepatide / yr (modeled) | — | $2,196 |
| Coverage | 48 states + Washington, D.C. — excludes Alaska and Mississippi | Coverage not published |
| Oral / sublingual | Yes | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #242 | #243 |
FORM
60/100Where the value is
- Both compounded AND branded (Wegovy/Zepbound) pathways on one account, plus NAD+, sermorelin, glutathione and a hair-loss line
- LegitScript and HIPAA-compliance badges both displayed
- Specific, named state exclusions (Alaska, Mississippi) rather than a vague coverage claim
The tradeoffs
- The advertised '$95/mo' Wegovy price is a MEMBERSHIP FEE ONLY — the drug itself is billed separately and its cost is not disclosed anywhere on the site
- No tirzepatide, Zepbound, NAD+, sermorelin, or hair-loss pricing published anywhere reachable
LumiMeds
60/100Where the value is
- Named, credentialed Medical Director (Dr. Teresa Walsh, M.D., board certified in obesity medicine, licensed in all 50 states) rather than an anonymous 'board-certified physicians' claim
- LegitScript Certified and HIPAA compliant
- No membership requirement or subscription fee stated separately from the medication price
The tradeoffs
- Both headline prices are explicitly 'as low as' figures across monthly/3/6/12-month options, and the site does not publish what the plain month-to-month rate is versus the prepay-discounted floor — the true standalone monthly cost could not be confirmed
- Compounded medications are, by the site's own disclosure, 'not FDA-approved and have not been evaluated for safety and effectiveness by the FDA'
Regulatory note: the FDA issued a warning letter to Lumimeds in September 2025. We still list and link to LumiMeds; you should know the letter is on the public record before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.